Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.08.2019 | Case report

Carfilzomib

Macrocytic anaemia by oxidative haemolysis: 8 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

A report described eight patients (two women and six men) aged 42−73 years treated in 2018, who developed macrocytic anaemia by oxidative haemolysis during treatment with carfilzomib for myeloma. …
Literatur
Zurück zum Zitat Rajagopal R, et al. High dose carfilzomib proteasome inhibition induces anemia by oxidative hemolysis: A case series of 8 patients from a single centre. American Journal of Hematology 94: E215-E216, No. 8, Aug 2019. Available from: URL: http://doi.org/10.1002/ajh.25504 - New Zealand Rajagopal R, et al. High dose carfilzomib proteasome inhibition induces anemia by oxidative hemolysis: A case series of 8 patients from a single centre. American Journal of Hematology 94: E215-E216, No. 8, Aug 2019. Available from: URL: http://​doi.​org/​10.​1002/​ajh.​25504 - New Zealand
Metadaten
Titel
Carfilzomib
Macrocytic anaemia by oxidative haemolysis: 8 case reports
Publikationsdatum
01.08.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-65848-7

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Azacitidine

Case report

Pembrolizumab

Case report

Methotrexate